文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症COVID-19幸存者短期健康相关生活质量、躯体功能与心理后遗症

Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19.
PubMed 文献 · Ann Intensive Care · 2021-06-04
一句话结论重症COVID-19有创机械通气幸存者出院约2个月存在轻中度功能受损、生活质量轻度下降,66%存在创伤后应激症状,6个月时疼痛与抑郁/焦虑未改善或加重。

该前瞻性观察性队列研究在随访门诊纳入47例重症COVID-19有创机械通气后存活出院的患者,平均年龄59±10岁,病前CFS中位2分。出院约2个月时6分钟步行距离中位470米(预测值83%),约1/3患者低于预测值84%;EQ-5D-5L的VAS在早期随访为80分、6个月轻度升至85分,活动能力、自我照顾和日常活动改善,而疼痛/不适与抑郁/焦虑未改善或加重。41名应答者中27人(66%)IES-R总分超过1.6的关注阈值。结论提示重症COVID-19幸存者出院早期存在轻中度功能受损和较多创伤后应激症状,需关注心理与疼痛症状的长期随访。

要点

  • 47例有创机械通气COVID-19幸存者出院约2个月6分钟步行距离中位470米,为预测值的83%,约1/3患者低于预测值84%。
  • 病前功能良好(CFS 1或2分)者中4/18(22%)6分钟步行距离低于预测值84%。
  • EQ-5D-5L的VAS早期随访80分,6个月轻度升至85分;活动能力、自我照顾、日常活动改善,疼痛/不适与抑郁/焦虑未改善或加重。
  • 41名IES-R应答者中27人(66%)总分超过1.6的关注阈值,提示出院早期创伤后应激症状比例高。
  • 随访人群病前CFS中位2分,提示入组者总体病前功能状态较好。

适用人群与场景

  • 本ICU收治的重症COVID-19有创机械通气后存活出院患者,共47例,平均年龄59±10岁,病前CFS中位2分[2-3]。
  • 在随访门诊完成评估;6分钟步行试验与EQ-5D-5L在出院约2个月(早期随访)进行,EQ-5D-5L在6个月重复,IES-R在2个月以匿名网络问卷完成。

诊断标准与关键阈值

  • IES-R总分大于1.6为关注阈值,41名应答者中27人(66%)超过该阈值。
  • 6分钟步行距离以预测值的84%为界,低于该值视为低于预测;总体约1/3患者低于预测值84%,病前CFS 1或2分者中4/18(22%)低于预测值84%。

研究设计与关键结果

  • 前瞻性观察性队列研究,47例重症COVID-19有创机械通气幸存者,在随访门诊评估出院约2个月和6个月的健康相关生活质量、躯体功能及创伤后应激症状。
  • 6分钟步行距离中位470米[406-516],为预测值的83%[67-99]%;总体约1/3患者、病前CFS 1或2分者中4/18(22%)低于预测值84%。
  • EQ-5D-5L的VAS早期随访为80分[70-90](满分100),6个月轻度改善至85分[77.5-90]。
  • 活动能力、自我照顾和日常活动在早期随访至6个月间改善;疼痛/不适和抑郁/焦虑未改善或加重。
  • IES-R总分在41名应答者中27人(66%)大于1.6的关注阈值。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,重症COVID-19有创机械通气幸存者出院早期存在轻中度功能受损、生活质量轻度下降,活动能力、自我照顾和日常活动总体改善,但6个月时疼痛和抑郁/焦虑症状加重,出院后不久创伤后痛苦症状比例高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Survivors of severe COVID-19 are at risk of impaired health-related quality of life (HRQoL) and persistent physical and psychological disability after ICU and hospital discharge. The subsequent social burden is a major concern. We aimed to assess the short-term HRQoL, physical function and prevalence of post-traumatic stress symptoms of invasively mechanically ventilated COVID-19 patients treated in our ICU.

METHODS: Prospective, observational cohort study in a follow-up clinic. Patients completed a 6-min walking test (6MWT) to assess their cardio-pulmonary function around 2 months (early follow-up) from hospital discharge, the EQ-5D-5L questionnaire for quality of life assessment around 2 months and at 6 months from hospital discharge and an anonymous web-based Impact of Event Scale-Revised (IES-R) questionnaire for Post-Traumatic Stress symptoms at 2 months.

RESULTS: 47 patients attended our follow-up program, mean age 59 ± 10 years, median pre-morbid Clinical Frailty Scale (CFS) 2 [2-3]. The median distance walked in 6 min was 470 [406-516] m, 83 [67-99]% of the predicted value. Overall 1 out 3 patients and 4/18 (22%) among those with a good functional baseline prior to COVID-19 (CFS of 1 or 2) had lower (84%) than predicted 6MWT. EQ-5D-5L quality of life VAS was 80 [70-90] out of 100 at early follow-up with a slight improvement to 85 [77.5-90] at 6 months. Mobility, self-care and usual activities improved between the two timepoints, while pain/discomfort and depression/anxiety did not improve or got worse. The IES-R total score was greater than the threshold for concern of 1.6 in 27/41(66%) respondents.

CONCLUSIONS: Patients recovering from severe COVID-19 requiring invasive mechanical ventilation surviving hospital discharge present with early mild to moderate functional impairment, mildly reduced quality of life from hospital discharge with an overall improvement of mobility, self-care and the ability of performing usual activities, while a worsening of pain and depression/anxiety symptoms at 6 months and a large proportion of symptoms of post-traumatic distress soon after hospital discharge.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Carenzo L, Protti A, Dalla Corte F, et al. Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19. Ann Intensive Care. 2021. PMID: 34089104. doi:10.1186/s13613-021-00881-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。